Sources | Names Used |
---|---|
GDSC1000 | KIN001-260 |
PharmacoGx | KIN001-260 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | YAP1 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.006 |
mRNA | GPR84 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.006 |
mRNA | MCM9 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.006 |
mRNA | FCGR2B | GDSC1000 | pan-cancer | AAC | 0.096 | 0.006 |
mRNA | TLR8 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.006 |
mRNA | RDM1 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.006 |
mRNA | MDN1 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.006 |
mRNA | ARHGAP32 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.006 |
mRNA | MAFK | GDSC1000 | pan-cancer | AAC | -0.09 | 0.006 |
mRNA | CCL1 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.006 |